Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention

High Blood Press Cardiovasc Prev. 2020 Oct;27(5):373-377. doi: 10.1007/s40292-020-00401-1. Epub 2020 Jul 30.


In 2020, the Sars-Cov-2 pandemic is causing a huge and dramatic impact on healthcare systems worldwide. During this emergency, fragile patients suffering from other comorbidities, especially patients susceptible to or affected by cardiovascular disease, are the ones most exposed to the poorer outcomes. Therefore, it is still mandatory to continue to strictly adhere to the rules of cardiovascular prevention. This document aims to provide all doctors with simple and clear recommendations in order to spread useful messages to the widest number of subjects in order to continue the battle against cardiovascular diseases even in times of pandemic.

Keywords: Cardiovascular prevention; Cardiovascular risk; Covid-19; Sars-Cov-2.

Publication types

  • Practice Guideline

MeSH terms

  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Cardiology / standards*
  • Cardiovascular Agents / adverse effects
  • Cardiovascular Agents / therapeutic use*
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / prevention & control*
  • Consensus
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / therapy*
  • Coronavirus Infections / virology
  • Host-Pathogen Interactions
  • Humans
  • Pandemics
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / therapy*
  • Pneumonia, Viral / virology
  • Preventive Health Services / standards*
  • Risk Assessment
  • Risk Factors
  • Risk Reduction Behavior*
  • SARS-CoV-2


  • Cardiovascular Agents